Arrowhead Research | Umlaufvermögen



Current Assets Veränderung Datum
Agios Pharmaceuticals USD 965.6M 108.59M 2024-12
Alnylam Pharmaceuticals USD 3.3B 60.14M 2024-12
Arrowhead Research USD 570.54M 124.93M 2024-12
Incyte USD 3.24B 430.32M 2024-12
Ionis Pharmaceuticals USD 2.62B 93.56M 2024-12
Ligand Pharmaceuticals USD 331.56M 22.17M 2024-12
Merck USD 38.78B 1.58B 2024-12
Moderna USD 8.1B 1.57B 2024-12
Novartis USD 29.7B 1.56B 2024-12
Sarepta Therapeutics USD 3.07B 388.09M 2024-12
TG Therapeutics USD 566.36M 7.71M 2024-12
Ultragenyx Pharmaceutical USD 817.12M 17.52M 2024-12
Vertex Pharmaceuticals USD 9.6B 207.7M 2024-12
Xencor USD 577.6M 4.27M 2024-12



Arrowhead Research Umlaufvermögen - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Apr 2025.